skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.1019-1045 [Peer Reviewed Journal]

2022 Kishore et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Kishore et al. 2022 Kishore et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S209395 ;PMID: 35418744

Full text available

Citations Cited by
  • Title:
    Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review
  • Author: Kishore, Kamal ; Bhat, Pooja V ; Venkatesh, Pradeep ; Canizela, Cecilia C
  • Subjects: Analysis ; Care and treatment ; Central nervous system depressants ; Dexamethasone ; diabetic macular edema ; Dropsy ; Edema ; intravitreal dex implant ; Medical research ; Medicine, Experimental ; ozurdex ; Pharmaceutical industry ; retinal vein occlusion ; Review ; uveitic macular edema ; Uveitis
  • Is Part Of: Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.1019-1045
  • Description: The purpose of this review article is to provide a comprehensive review of the current applications of intravitreal DEX implant (Ozurdex , Allergan Inc, Irvine, CA) for a variety of ophthalmic conditions - ranging from FDA approved indications to off-label uses. We have attempted to provide relevant evidence from the literature to help a reader develop an understanding of the biological and pharmacokinetic properties of DEX implant, its uses, and potential side effects. PubMed searches were performed using the terms "Ozurdex", or "intravitreal DEX implant", AND "retinal vein occlusion", or "diabetic macular edema", or "uveitis". The search was performed in July of 2021, with an additional search in October 2021. All original English language articles were considered for this review. DEX implant has evidence of efficacy in a variety of clinical situations including macular edema associated with retinal vein occlusion, diabetes, uveitis, and others. Safety concerns include cataract formation and progression, intraocular pressure elevation, complications related to intravitreal injection, and opportunistic infections secondary to steroid-induced immune suppression. DEX implant is a useful tool in the management of several retinal disorders. Further studies are needed for head-to-head comparison with other treatment modalities and to determine its precise place in clinical practice.
  • Publisher: New Zealand: Dove Medical Press Limited
  • Language: English
  • Identifier: ISSN: 1177-5467
    ISSN: 1177-5483
    EISSN: 1177-5483
    DOI: 10.2147/OPTH.S209395
    PMID: 35418744
  • Source: GFMER Free Medical Journals
    PubMed Central
    DOVE Medical Press Journals
    ProQuest Central
    DOAJ Directory of Open Access Journals
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait